KR20060006047A - Ｈｉｖ 인테그레이즈 저해제 - Google Patents

Ｈｉｖ 인테그레이즈 저해제 Download PDF

Info

Publication number
KR20060006047A
KR20060006047A KR1020057020004A KR20057020004A KR20060006047A KR 20060006047 A KR20060006047 A KR 20060006047A KR 1020057020004 A KR1020057020004 A KR 1020057020004A KR 20057020004 A KR20057020004 A KR 20057020004A KR 20060006047 A KR20060006047 A KR 20060006047A
Authority
KR
South Korea
Prior art keywords
het
alkyl
alkynyl
alkenyl
cycloalkyl
Prior art date
Application number
KR1020057020004A
Other languages
English (en)
Korean (ko)
Inventor
윔 가스통 베르슈에렌
인지 디에린크
도미니크 루이스 네스터 기스레인 서레러스
프레드릭 프랜스 데자이어 대애르트
Original Assignee
티보텍 파마슈티칼즈 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 티보텍 파마슈티칼즈 리미티드 filed Critical 티보텍 파마슈티칼즈 리미티드
Publication of KR20060006047A publication Critical patent/KR20060006047A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1020057020004A 2003-04-28 2004-04-27 Ｈｉｖ 인테그레이즈 저해제 KR20060006047A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US46598703P 2003-04-28 2003-04-28
US60/465,987 2003-04-28
EP03101164.6 2003-04-28
EP03101164 2003-04-28

Publications (1)

Publication Number Publication Date
KR20060006047A true KR20060006047A (ko) 2006-01-18

Family

ID=33420586

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057020004A KR20060006047A (ko) 2003-04-28 2004-04-27 Ｈｉｖ 인테그레이즈 저해제

Country Status (13)

Country Link
US (1) US20060211724A1 (zh)
EP (1) EP1625130A2 (zh)
KR (1) KR20060006047A (zh)
CN (1) CN1812992A (zh)
AP (1) AP2005003451A0 (zh)
AR (1) AR044518A1 (zh)
AU (1) AU2004234087A1 (zh)
BR (1) BRPI0409873A (zh)
CA (1) CA2522990A1 (zh)
MX (1) MXPA05011726A (zh)
NO (1) NO20055230L (zh)
TW (1) TW200507848A (zh)
WO (1) WO2004096807A2 (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1888581A2 (en) * 2005-05-16 2008-02-20 Gilead Sciences, Inc. Hiv-integrase inhibitor compounds
US8013159B2 (en) 2005-05-19 2011-09-06 Merck Canada Inc. Quinoline derivatives as EP4 antagonists
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
JP2009502964A (ja) * 2005-07-27 2009-01-29 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖを阻害するための抗ウイルス性ホスホン酸結合体
US20080039487A1 (en) * 2005-12-21 2008-02-14 Gilead Sciences, Llc Processes and intermediates useful for preparing integrase inhibitor compounds
AU2007254190A1 (en) * 2006-05-16 2007-11-29 Gilead Sciences, Inc. Integrase inhibitors
EP1916249A1 (en) * 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
US8093265B2 (en) 2007-03-09 2012-01-10 Renovis, Inc. Bicycloheteroaryl compounds as P2X7 modulators and uses thereof
WO2009067541A2 (en) * 2007-11-20 2009-05-28 Gilead Sciences, Inc. Integrase inhibitors
EP2254582B1 (en) 2008-01-25 2016-01-20 Chimerix, Inc. Methods of treating viral infections
US8822500B2 (en) 2008-03-19 2014-09-02 Chembridge Corporation Tyrosine kinase inhibitors
JP5628145B2 (ja) 2008-03-19 2014-11-19 ケムブリッジ・コーポレーション 新規チロシンキナーゼ阻害剤
US9249147B2 (en) 2008-03-19 2016-02-02 Chembridge Corporation Tyrosine kinase inhibitors
MX2011010582A (es) * 2009-04-09 2011-10-19 Boehringer Ingelheim Int Inhibidores de la replicacion del vih.
US8283366B2 (en) 2010-01-22 2012-10-09 Ambrilia Biopharma, Inc. Derivatives of pyridoxine for inhibiting HIV integrase
US9006218B2 (en) 2010-02-12 2015-04-14 Chimerix Inc. Nucleoside phosphonate salts
US10513515B2 (en) 2017-08-25 2019-12-24 Biotheryx, Inc. Ether compounds and uses thereof
AU2019309894A1 (en) 2018-07-27 2021-01-28 Biotheryx, Inc. Bifunctional compounds as CDK modulators
US11897930B2 (en) 2020-04-28 2024-02-13 Anwita Biosciences, Inc. Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544732B1 (en) * 1999-05-20 2003-04-08 Illumina, Inc. Encoding and decoding of array sensors utilizing nanocrystals
EP1326610B1 (en) * 2000-10-12 2006-11-15 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
US20040157804A1 (en) * 2002-10-16 2004-08-12 Gilead Sciences, Inc. Pre-organized tricyclic integrase inhibitor compounds
US7442773B2 (en) * 2004-01-23 2008-10-28 The Board Of Trustees Of The University Of Illinois Universal peptide-binding scaffolds and protein chips

Also Published As

Publication number Publication date
BRPI0409873A (pt) 2006-05-16
CN1812992A (zh) 2006-08-02
AR044518A1 (es) 2005-09-14
TW200507848A (en) 2005-03-01
NO20055230L (no) 2005-11-07
EP1625130A2 (en) 2006-02-15
US20060211724A1 (en) 2006-09-21
WO2004096807A2 (en) 2004-11-11
MXPA05011726A (es) 2006-01-23
WO2004096807A8 (en) 2005-09-22
WO2004096807A3 (en) 2005-01-06
CA2522990A1 (en) 2004-11-11
AP2005003451A0 (en) 2005-12-31
AU2004234087A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
KR20060006047A (ko) Ｈｉｖ 인테그레이즈 저해제
JP5156150B2 (ja) 新規な多環式化合物およびそれらの使用
JP5385133B2 (ja) 新規多環式化合物およびその使用
KR101669311B1 (ko) Ｊａｋ２ 억제제, 및 골수증식성 질환 및 암의 치료를 위한 그의 용도
EP2137188B1 (de) Substituierte imidazo- und triazolopyrimidine
EP2582668B1 (en) Carboline carboxamide compounds useful as kinase inhibitors
KR100710402B1 (ko) 3환식 축합 이항환 화합물, 그 제조법 및 그것을 함유하는의약
JP5557849B2 (ja) カルバゾールおよびカルボリンキナーゼ阻害剤
TW202200567A (zh) 用於治療疾病之磷酸肌醇3-激酶(pi3k)異位色烯酮抑制劑
JP2007534739A (ja) ピロロピリジン誘導体及びｈｉｖインテグラーゼ酵素阻害剤としてのその使用
TW201004956A (en) Pyrazolo[3,4-b]pyridine compounds, and their use as phosphodiesterase inhibitors
WO2008021369A2 (en) Tricyclic compounds and its use as tyrosine kinase modulators
TW201219391A (en) Inhibitors of PI3K-delta and methods of their use and manufacture
JPH06508366A (ja) イミダゾ〔１，５−ａ〕キノキサリン
TWI601724B (zh) 咪唑並喹啉類衍生物及其可藥用鹽、其製備方法及其在醫藥上的應用
Slater et al. Indolocarbazoles: potent, selective inhibitors of human cytomegalovirus replication
FR2907453A1 (fr) Nouveaux derives du fluorene,compositions les contenant et utilisation
EP1751157B1 (en) Inhibitors of the hiv integrase enzyme
CN105820165B (zh) α-咔啉类化合物，其制备方法以及用途
CN117043153A (zh) 作为gls1抑制剂的杂环化合物
JP2009511463A (ja) Ｈｉｖインテグラーゼ酵素の阻害剤
ZA200508734B (en) HIV integrase inhibitors
JP2009510157A (ja) Ｈｉｖインテグラーゼ酵素の阻害剤
TW202415658A (zh) 含氮雜環類化合物及其醫藥用途
CN118139862A (zh) 含氮杂环类化合物及其医药用途

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid